Table 1 Characteristics of the patients and workflow measures at baseline.*
From: A study on endovascular treatment alone and bridging treatment for acute ischemic stroke
Variable | EVT (N = 78) | IV + EVT (N = 62) | p Value |
|---|---|---|---|
Mean age ± SD—yr | 63.01 ± 11.42 | 65.29 ± 10.71 | 0.194 |
Male sex—no. (%) | 37 (47.4) | 45 (72.6) | 0.024 |
Medical history—no. (%) | |||
Atrial fibrillation | 27 (34.6) | 17 (27.4) | 0.113 |
Diabetes mellitus | 10 (12.8) | 12 (19.4) | 0.128 |
Hypertension | 37 (47.4) | 30 (48.4) | 0.819 |
Ischemic stroke or transient ischemic attack | 19 (24.4) | 8 (12.9) | 0.233 |
Prior or current smoker | 26 (33.3) | 15 (24.2) | 0.334 |
No symptoms on modified Rankin scale before stroke—no. (%) | 21 (84.0) | 30 (48.4) | 0.064 |
NIHSS score† | |||
Median (IQR) | 15 (4–39) | 14 (4–32) | 0.132 |
6–16—no. (%) | 43 (55.1) | 41 (66.1) | |
17 or more—no. (%) | 35 (44.9) | 21 (33.9) | |
Median systolic blood pressure at hospital arrival (IQR)—mmHg | 136 (79–210) | 141 (106–196) | 0.194 |
Median glucose level at hospital arrival (IQR)—mmol/liter‡ | 6.11 (3.7–50.3) | 5.83 (3.8–15.7) | 0.695 |
Median ASPECTS value (IQR)§ | 8.0 (6.0–10.0) | 8.0 (6.0–10.0) | 0.069 |
Occlusion location, No. (%) | |||
ICA | 25 (32.0) | 20 (32.3) | 0.876 |
M1 MCA | 41 (52.6) | 35 (56.5) | |
M2 MCA | 12 (15.4) | 7 (11.2) | |
Workflow times | |||
Median time from stroke onset to intravenous alteplase (IQR)—min | NA | 176 (56–270) | |
Median time from stroke onset to groin puncture (IQR)—min | 396 (24–600) | 271 (43–600) | 0.002 |
Under 4.5 h—no. (%) | 24 (30.7) | 31 (50.0) | |
4.5–6 h—no. (%) | 10 (12.8) | 15 (24.2) | |
6–8 h—no. (%) | 25 (32.1) | 11 (17.7) | |
8–10 h—no. (%) | 19 (24.4) | 5 (8.1) | |
Median time from stroke onset to revascularization (IQR)—min | 469 (67–1140) | 380 (140–731) | 0.009 |